QIPT vs. AIRS, VMD, TOI, CORBF, DCGO, SERA, XGN, EUDA, NAKA, and KDLY
Should you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include AirSculpt Technologies (AIRS), Viemed Healthcare (VMD), Oncology Institute (TOI), Global Cord Blood (CORBF), DocGo (DCGO), Sera Prognostics (SERA), Exagen (XGN), EUDA Health (EUDA), KindlyMD (NAKA), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry.
Quipt Home Medical vs. Its Competitors
AirSculpt Technologies (NASDAQ:AIRS) and Quipt Home Medical (NASDAQ:QIPT) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.
AirSculpt Technologies has a beta of 2.46, suggesting that its stock price is 146% more volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.56, suggesting that its stock price is 44% less volatile than the S&P 500.
Quipt Home Medical has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Quipt Home Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Quipt Home Medical had 4 more articles in the media than AirSculpt Technologies. MarketBeat recorded 5 mentions for Quipt Home Medical and 1 mentions for AirSculpt Technologies. AirSculpt Technologies' average media sentiment score of 1.02 beat Quipt Home Medical's score of 0.34 indicating that AirSculpt Technologies is being referred to more favorably in the media.
AirSculpt Technologies currently has a consensus target price of $3.75, indicating a potential downside of 30.43%. Quipt Home Medical has a consensus target price of $2.85, indicating a potential upside of 64.74%. Given Quipt Home Medical's stronger consensus rating and higher possible upside, analysts clearly believe Quipt Home Medical is more favorable than AirSculpt Technologies.
91.5% of AirSculpt Technologies shares are held by institutional investors. Comparatively, 42.9% of Quipt Home Medical shares are held by institutional investors. 76.6% of AirSculpt Technologies shares are held by insiders. Comparatively, 13.4% of Quipt Home Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Quipt Home Medical has a net margin of -3.66% compared to AirSculpt Technologies' net margin of -9.95%. Quipt Home Medical's return on equity of -8.38% beat AirSculpt Technologies' return on equity.
Summary
Quipt Home Medical beats AirSculpt Technologies on 12 of the 17 factors compared between the two stocks.
Get Quipt Home Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding QIPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quipt Home Medical Competitors List
Related Companies and Tools
This page (NASDAQ:QIPT) was last updated on 7/7/2025 by MarketBeat.com Staff
